In Brief
- 1/15/2010
Novel Personalized Medicine Trial Launched for Metastatic Colorectal Cancer - 6/22/2009
CAPMM Scientist Receives International Recognition for Innovative Nanotechnology Research - 4/26/2009
In the News: "Summertime, and the Living Is In a Lab - 12/17/2008
In the News: "Pioneering Mind-Set at George Mason Produces New HGH Test"
"Our major goal is to advance discoveries and technology development to patient-tailored research and personalized medicine."
Lance A. Liotta, MD, PhD
Co-director, CAPMM
The Center for Applied Proteomics and Molecular Medicine is a key element of the Life Sciences initiative in the College of Science.
Lance A. Liotta and Emanuel F. Petricoin III co-founded the Center for Applied Proteomics and Molecular Medicine in 2005.
Scientists envision a new paradigm for early diagnosis and personalized management of disease.
Innovative discoveries, visionary thinking, and critical sharing of ideas result from dedicated partnerships.